Skip Ribbon Commands
Skip to main content
Skip over global navigation links
U.S. Department of Health and Human Services

Federal Partners

2016 PHEMCE Stakeholders Workshop

Making sure the nation has the drugs, vaccines, and medical devices needed to protect health in an emergency requires more money, authority, and technical expertise than any one federal agency has alone. But by collaborating, federal agencies are making it happen and the Public Health Emergency Medical Countermeasures Enterprise is one important mechanism to make sure that those connections are made before an infectious disease outbreak or terrorist attack.

For example, during the Ebola outbreak that spread to many countries in West Africa and became a public health emergency of international concern, federal agencies in the United States pulled together to rapidly review the medical countermeasures that different agencies were supporting – none of them had reached clinical trials. Agency representatives worked together to make critical decisions that helped move these products forward.

If you are a member of a federal agency that is involved in the research, development, procurement or deployment of medical countermeasures and you want to help meet the challenges that emerging infectious diseases and terrorist threats pose to our nation’s health, join us for the Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) Stakeholders Workshop on January 6-7, 2016.

The PHEMCE Stakeholders Workshop gives you an opportunity to learn about emerging trends and network with your federal colleagues as well as colleagues in the pharmaceutical, heath care, first responder and emergency management communities as well as state and local officials.

During this event, you can contribute to discussions on the development, procurement, deployment and use of medical countermeasures in a disaster. We’ll talk about lessons learned from Ebola and pandemic influenza outbreaks; partnering effectively with industry; PHEMCE preparedness goals and operational capacity; clinical guidance on the use of medical countermeasures; and the Strategic National Stockpile.

Join professionals from the front lines of health to the production lines of the pharmaceutical companies and medical device manufacturers who develop medical countermeasures. Register today!

Logistical Details

  • This page last reviewed: December 29, 2015